Products
Online Inquiry
Lenalidomide (CC-5013)
Cat. No.:
OB0225WX-2387
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Lenalidomide is a ligand for the cereblon (CRBN) E3 ubiquitin ligase that induces the selective degradation of transcription factors IKZF1 and IKZF3 while inhibiting TNF-alpha secretion (IC50: 13 nM).
Synonym:
CC-5013; 191732-72-6; Revlimid; Revimid; 3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; CC-5013; CDC 501; CDC-501; Lenalidomide (CC-5013); 2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-; 3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; IMiD3; CC 5013; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione; Lenadoamide; MFCD07772307; (3S)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline; 3-(4-amino-1-oxo-2,3-dihydro-1H-isoindol-2-yl)piperidine-2,6-dione; 3-(4-Amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione; IMiD3 cpd; lenalidomidum; Lenalidomida; 3-(4-Amino-1-oxo-2-isoindolinyl)piperidine-2,6-dione; 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione; 2, 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-; 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-2,6-dioxopiperidine; (3RS)-3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione; 4-amino-2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-2,3-dihydro-1H-isoindol-1-one
CAS No.:
191732-72-6
Compound CID:
216326
Formula:
C13H13N3O3
Formula Weight:
259.26
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Lenalidomide is employed in hematology and immunology research as an immunomodulatory agent to investigate the degradation of specific ligase substrates and the inhibition of angiogenesis in multiple myeloma models.
Library Information
Target:
Caspase; E3 Ligase ; E3 ligase ligand; TNF-alpha; VEGFR
Receptor:
Caspase; E3 Ligase ; E3 ligase ligand; TNF-alpha; VEGFR
Pathways:
Ubiquitin
Plate Number:
L6700-01
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
52 mg/mL; 200.57 mM
ALogP:
-0.515
HBA_Count:
3
HBD_Count:
2
Rotatable Bond:
1



